Key facts
- Sonaro’s last known valuation is $4.4M (Dec 2024).
- It has raised $140K; the latest was Angel (individual) in Apr 2026.
- Notable investors include Creative Destruction Lab, University of Toronto Entrepreneurship, Centech Accelerator, Front Row Ventures, Québec Tech — 21 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 21 names
- ·Watchlist + deal alerts for Sonaro
- ·The full record, as it builds
Funding rounds
No funding rounds for Sonaro are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Sonaro
Developer of an ultrasound diagnostic artificial intelligence-based technology designed to predict the risk of thromboembolic events. The company's AI-powered offer a flagship product that converts traditional two-dminsional ultrasound data into accurate three-dimensional models of the carotid arteries and improves stroke risk assessment by diagnostic accuracy, reducing operator workload, and delivering results in minutes, making diagnostic ultrasound for vascular diseases accessible to every individual, enabling clinicians to obtain detailed clinical reports on vascular characteristics like volume and the presence of high-risk features.
- Sector
- Healthcare
- HQ
- Montreal, Canada
- Employees
- 6
- Website
- sonaro-ai.com/
- Ownership
- Privately Held (backing)
Sonaro doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Sonaro shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Sonaro in its N-PORT filings yet. We sweep new filings monthly.